TCRX
TScan Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.69 / 10
Netural
Fund flow score 7.38 (good) with modest overall inflow (0.43) but negative trend; small trades are positive while larger sizes are negative. Analyst coverage is limited to one Buy rating, historically 0% win rate, and market sentiment is pessimistic.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-05
InstitutionWedbush
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of TCRX?
- TCRX holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.69/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
